Literature DB >> 24854451

Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study.

Junichi Shindoh1, Xabier de Aretxabala, Thomas A Aloia, Juan Carlos Roa, Ivan Roa, Giuseppe Zimmitti, Milind Javle, Claudius Conrad, Dipen M Maru, Taku Aoki, Luca Vigano, Dario Ribero, Norihiro Kokudo, Lorenzo Capussotti, Jean-Nicolas Vauthey.   

Abstract

OBJECTIVE: To determine the prognostic impact of tumor location in gallbladder cancer.
BACKGROUND: Depth of tumor is a strong predictor of survival after curative resection of gallbladder cancer. However, the gallbladder has a unique anatomical relationship with the liver, and the clinical significance of tumor location remains unclear.
METHODS: For 437 patients with gallbladder cancer who underwent resection at 4 international institutions, clinicopathologic characteristics and their association with survival were analyzed. Tumor location was defined as "hepatic side" or "peritoneal side," and the prognostic significance of tumor location was evaluated.
RESULTS: Among the 252 patients with T2 disease, patients with tumors on the hepatic side (T2h, n = 99) had higher rates of vascular invasion, neural invasion, and nodal metastasis than patients with tumors on the peritoneal side (T2p, n = 153) (51% vs 19%, 33% vs 8%, and 40% vs 17%, respectively; P < 0.01 for all). After a median follow-up of 58.9 months, 3-year and 5-year survival rates were 52.1% and 42.6%, respectively, for T2h tumors and 73.7% and 64.7%, respectively, for T2p tumors (P = 0.0006). No such differences were observed in T1 or T3 tumors. Multivariate analysis confirmed the independent association of hepatic-side location with survival in T2 tumors (hazard ratio, 2.7; 95% confidence interval, 1.7-4.2; P < 0.001). This subclassification of T2 tumors predicted recurrence in the liver (23% vs 3%; P = 0.003) and distant lymph nodes (16% vs 3%; P = 0.019) even after radical resection.
CONCLUSIONS: After curative resection of T2 gallbladder cancer, tumor location predicts the pattern of recurrence and survival.

Entities:  

Mesh:

Year:  2015        PMID: 24854451      PMCID: PMC4800978          DOI: 10.1097/SLA.0000000000000728

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  14 in total

1.  Carcinoma of the gallbladder: a study of its modes of spread.

Authors:  R B FAHIM; J R McDONALD; J C RICHARDS; D O FERRIS
Journal:  Ann Surg       Date:  1962-07       Impact factor: 12.969

2.  Perimuscular connective tissue contains more and larger lymphatic vessels than the shallower layers in human gallbladders.

Authors:  Masayuki Nagahashi; Yoshio Shirai; Toshifumi Wakai; Jun Sakata; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

3.  Benefits of reoperation of T2 and more advanced incidental gallbladder carcinoma: analysis of the German registry.

Authors:  Thorsten Oliver Goetze; Vittorio Paolucci
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

4.  Biology dictates prognosis following resection of gallbladder carcinoma: sometimes less is more.

Authors:  Timothy M Pawlik; Michael A Choti
Journal:  Ann Surg Oncol       Date:  2009-01-23       Impact factor: 5.344

Review 5.  Key factors influencing prognosis in relation to gallbladder cancer.

Authors:  Charles Henry Caldow Pilgrim; Ryan T Groeschl; Kiran K Turaga; T Clark Gamblin
Journal:  Dig Dis Sci       Date:  2013-05-22       Impact factor: 3.199

6.  Strategies for surgical treatment of gallbladder carcinoma based on information available before resection.

Authors:  Norihiro Kokudo; Masatoshi Makuuchi; Takeshi Natori; Yoshihiro Sakamoto; Junji Yamamoto; Makoto Seki; Tamaki Noie; Yasuhiko Sugawara; Hiroshi Imamura; Shingo Asahara; Takaaki Ikari
Journal:  Arch Surg       Date:  2003-07

7.  Management of T2 gallbladder cancer: are practice patterns consistent with national recommendations?

Authors:  Byron E Wright; Chris C Lee; Douglas M Iddings; Maihgan Kavanagh; Anton J Bilchik
Journal:  Am J Surg       Date:  2007-12       Impact factor: 2.565

8.  Microscopic liver metastasis: prognostic factor for patients with pT2 gallbladder carcinoma.

Authors:  Itaru Endo; Hiroshi Shimada; Atsushi Takimoto; Yoshiro Fujii; Yasuhiko Miura; Mitsutaka Sugita; Daisuke Morioka; Hideki Masunari; Kuniya Tanaka; Hitoshi Sekido; Shinji Togo
Journal:  World J Surg       Date:  2004-06-04       Impact factor: 3.352

9.  Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan.

Authors:  Shuichi Miyakawa; Shin Ishihara; Akihiko Horiguchi; Tadahiro Takada; Masaru Miyazaki; Takukazu Nagakawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-12-26

10.  Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases.

Authors:  Y Shirai; S Kawata; S Tamura; N Ito; H Tsushima; K Takaishi; S Kiso; Y Matsuzawa
Journal:  Cancer       Date:  1994-05-01       Impact factor: 6.860

View more
  45 in total

1.  Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer.

Authors:  Heming Li; Tong Zhao; Xuening Ji; Shanshan Liang; Zhe Wang; Yulong Yang; Jiajun Yin; Ruoyu Wang
Journal:  Tumour Biol       Date:  2015-10-09

Review 2.  The Landmark Series: Gallbladder Cancer.

Authors:  Adriana C Gamboa; Shishir K Maithel
Journal:  Ann Surg Oncol       Date:  2020-05-30       Impact factor: 5.344

3.  Gallbladder cancer: expert consensus statement.

Authors:  Thomas A Aloia; Nicolas Járufe; Milind Javle; Shishir K Maithel; Juan C Roa; Volkan Adsay; Felipe J F Coimbra; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

4.  Validation of the prognostic performance in various nodal staging systems for gallbladder cancer: results of a multicenter study.

Authors:  Woohyung Lee; Chi-Young Jeong; Young Hoon Kim; Young Hoon Roh; Myung Hee Yoon; Hyung Il Seo; Jeong-Ik Park; Bo-Hyun Jung; Dong Hoon Shin; Young Il Choi; Je Ho Ryu; Kwang Ho Yang; Chang Soo Choi; Yo-Han Park; Yang Won Nah; Soon-Chan Hong
Journal:  Langenbecks Arch Surg       Date:  2019-08-14       Impact factor: 3.445

5.  Gallbladder Adenocarcinoma: the Impact of Tumor Location and Minimally Invasive Surgery on Survival.

Authors:  Felipe B Maegawa; Marah Hamdan; Ashtyn Barrientes; Alexander Philipovskiy; Sherif Elhanafi; Alan H Tyroch; Ioannis T Konstantinidis
Journal:  J Gastrointest Surg       Date:  2021-02-02       Impact factor: 3.452

Review 6.  Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria-What has changed and why?

Authors:  Luca Bertero; Federica Massa; Jasna Metovic; Roberto Zanetti; Isabella Castellano; Umberto Ricardi; Mauro Papotti; Paola Cassoni
Journal:  Virchows Arch       Date:  2017-12-05       Impact factor: 4.064

Review 7.  Multimodality Management of Localized Biliary Cancer.

Authors:  Nadia Ashai; Preethi Prasad; Lakshmi Rajdev
Journal:  Curr Treat Options Oncol       Date:  2019-05-29

Review 8.  Technical Aspects of Gallbladder Cancer Surgery.

Authors:  Motaz Qadan; T Peter Kingham
Journal:  Surg Clin North Am       Date:  2016-04       Impact factor: 2.741

9.  Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium.

Authors:  Georgios Antonios Margonis; Faiz Gani; Stefan Buettner; Neda Amini; Kazunari Sasaki; Nikolaos Andreatos; Cecilia G Ethun; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2016-08-13       Impact factor: 3.647

10.  Hepatectomy of segment 4b and 5 with extrahepatic bile duct resection for pT2 gallbladder carcinoma is valid: a single-institution result.

Authors:  Shunsuke Onoe; Yuji Kaneoka; Atsuyuki Maeda; Yuichi Takayama; Yasuyuki Fukami; Masatoshi Isogai
Journal:  Updates Surg       Date:  2015-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.